Previsioni di mercato della diagnostica molecolare point-of-care per Medio Oriente e Africa fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotti e servizi (test e kit, strumenti, servizi e software), tecnologia (PCR, tecnologia di amplificazione isotermica degli acidi nucleici ( INAAT) e altre tecnologie), Applicazione (Malattie infettive, Oncologia, Ematologia, Test prenatali, Endocrinologia e altre applicazioni), Utente finale (Ospedali e cliniche, Laboratori diagnostici, Istituti accademici e di ricerca e Altri)
Introduzione al mercato
La diagnostica molecolare al punto di cura comprende dispositivi portatili, test e analisi ; kit utilizzati per rilevare e diagnosticare malattie in campioni umani, come tamponi faringei, sangue, siero e feci. La diagnostica molecolare si sta spostando dai laboratori centralizzati ai test molecolari decentralizzati presso i punti di cura. Grazie alla sua semplicità, praticità, tempi di consegna rapidi e potenziale di miglioramento dei risultati sui pazienti, il POCT sta rapidamente guadagnando terreno.
Inoltre, la crescente domanda di metodi specifici di rilevamento virale che consumano si prevede che meno tempo per un controllo tempestivo delle infezioni rafforzerà la crescita del mercato durante il periodo di previsione.
Il Sud Africa ha segnalato i casi di COVID-19 più elevati in Medio Oriente e Africa, seguito da Arabia Saudita ed Emirati Arabi Uniti, tra gli altri. Le politiche del governo saudita hanno favorito la proliferazione dei produttori farmaceutici nazionali; il governo ha abolito i dazi all’importazione sulle materie prime e sui prodotti intermedi e ha facilitato il finanziamento sostenendo finanziamenti senza interessi. Allo stesso modo, l’incidenza in costante aumento del COVID-19 sta creando un’enorme domanda di kit e reagenti utilizzati nella sua diagnosi. Nell\'aprile 2020, BGI Group, una società cinese di genomica, e Group-42, una società tecnologica degli Emirati Arabi Uniti, hanno inaugurato un nuovo laboratorio ad alta produttività negli Emirati Arabi Uniti per supportare i test e la diagnosi del nuovo coronavirus. Secondo il gruppo BGI, il laboratorio utilizzerà kit diagnostici RT-PCR approvati dalle autorità di regolamentazione medica in Cina, Europa, Stati Uniti e Giappone. Poiché i kit di diagnostica molecolare point-of-care vengono utilizzati principalmente per il rilevamento di SARS-CoV-2, la pandemia sta alimentando la crescita del mercato.
Panoramica e dinamiche del mercato
Medio Oriente e Stati Uniti. Si prevede che il mercato africano della diagnostica molecolare point-of-care raggiungerà i 212,9 milioni di dollari entro il 2028 rispetto ai 94,0 milioni di dollari del 2021. Si stima che il mercato crescerà a un CAGR del 12,4% dal 2021 al 2028. I test molecolari point-of-care (POC) sono accurati e scalabili che aumentano la portata della diagnosi delle malattie, che può essere effettuata nella comunità e al di fuori del contesto di laboratorio. Rispetto ai test di laboratorio, la diagnostica molecolare presso il punto di cura offre vari vantaggi come un minor numero di visite cliniche, degenze ospedaliere più brevi, una migliore ottimizzazione della terapia farmacologica e un uso meno inappropriato dei farmaci. Il settore sanitario sta attraversando un’enorme trasformazione dovuta all’emergere di tecnologie nuove ed efficaci in tutto il settore. Pertanto, la crescente domanda di una diagnostica efficace che richieda meno tempo rispetto ai test di laboratorio spinge la domanda di test e kit molecolari POC che promuovono la crescita del Medio Oriente e del Medio Oriente. Mercato africano della diagnostica molecolare point-of-care nel periodo di previsione.
Segmenti chiave del mercato
In termini di prodotto e qualità servizi, il segmento dei test e dei kit rappresentava la quota maggiore del Medio Oriente e del Medio Oriente e dei kit. Mercato africano della diagnostica molecolare point-of-care nel 2020. In termini di tecnologia, il segmento PCR rappresentava la quota maggiore del Medio Oriente e del Medio Oriente. Mercato africano della diagnostica molecolare point-of-care nel 2020. In termini di applicazione, il segmento delle malattie infettive rappresentava la quota maggiore del Medio Oriente e dell\'Europa. Mercato africano della diagnostica molecolare point-of-care nel 2020. In termini di utente finale, il segmento dei laboratori diagnostici rappresentava la quota maggiore del Medio Oriente e del Medio Oriente. Mercato africano della diagnostica molecolare point-of-care nel 2020.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie citate per la preparazione di questo rapporto sul mercato della diagnostica molecolare point-of-care in Medio Oriente e Stati Uniti. Africa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti del governo nazionale e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, Meridian BioScience, Inc., Biocartis, Quidel Corporation e Bio-Rad Laboratories, Inc. .
Rapporto sui motivi per acquistare
- Capire il Medio Oriente e il Medio Oriente Panorama del mercato della diagnostica molecolare Point-of-Care in Africa e identificare segmenti di mercato che potrebbero garantire un forte ritorno
- Comprendere il panorama del mercato in continua evoluzione e rimanere al passo con la concorrenza
- Per pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership in Medio Oriente e in Medio Oriente. Mercato africano della diagnostica molecolare point-of-care identificando i segmenti con le vendite probabili più promettenti
- Prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa delle prestazioni di mercato dei vari segmenti
- Per ottenere previsioni sui ricavi di mercato del Medio Oriente e del Medio Oriente Mercato africano della diagnostica molecolare point-of-care basato su vari segmenti per il periodo dal 2021 al 2028
MEDIO ORIENTE & SEGMENTAZIONE DEL MERCATO DELLA DIAGNOSTICA MOLECOLARE POINT OF CARE IN AFRICA
Per Prodotto & Servizi
- Saggi e kit
- Strumenti
- Servizi e software
Per tecnologia
- PCR
- Tecnologia di amplificazione isotermica degli acidi nucleici (INAAT)
- Altre tecnologie
Di Applicazione
- Malattie infettive
- Oncologia
- Ematologia
- Test prenatali
- Endocrinologia
- Altre applicazioni
Di Utente finale
- Ospedali e cliniche
- Laboratori diagnostici
- Istituti accademici e di ricerca
- Altri
Per Paese
- Medio Oriente e Stati Uniti. Africa
- Emirati Arabi Uniti
- Arabia Saudita
- Sudafrica
- Resto del Medio Oriente e dell\'Africa Africa
Aziende citate
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 Middle East & Africa Point-of-Care Molecular Diagnostics Market– By Geography
2. Middle East & Africa Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– Middle East & Africa Analysis
6.1 Middle East & Africa Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East & Africa Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 Middle East & Africa: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.1.4 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.1.5 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.1.6 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.1.7 Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.1.7.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.1.3 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.1.4 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.1.5 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.2 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.2.3 South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.2.4 South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.2.5 South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.3 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.3.3 UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.3.4 UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.3.5 UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.4.3 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.4.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.4.5 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 2. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 3. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 14. UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 15. UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 22. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 23. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. Middle East & Africa Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in Middle East & Africa Point-of-Care Molecular Diagnostics Market
Figure 4. South Africa to Show Significant Growth During Forecast Period
Figure 5. Middle East & Africa Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. Middle East & Africa PEST Analysis
Figure 7. Middle East & Africa Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 29. Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 31. Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East & Africa
Figure 36. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Point-of-Care molecular diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.